Evaluation Of Terbinafine Activity On Pneumocystis Carinii At The Rat Model
Author(s) -
Müge Oğuzkaya Artan,
Nedret Koç,
Ahmet Öztürk
Publication year - 2009
Publication title -
trakya üniversitesi tıp fakültesi dergisi
Language(s) - English
Resource type - Journals
ISSN - 1301-3149
DOI - 10.5174/tutfd.2009.01682.2
Subject(s) - pneumocystis carinii , terbinafine , medicine , biology , microbiology and biotechnology , virology , human immunodeficiency virus (hiv) , antifungal , pneumocystis jirovecii , itraconazole
Objective: The purpose of this study was to test the hypothesis thThis study was planned to investigate the antipneumocystis activity of terbinafine in a rat model. Material and Methods: Rats were obtained from the Hakan Cetinsaya Experimental and Clinical Research Institutions, Erciyes University, Kayseri, Turkey. Terbinafine administered orally in doses of 40, 80, 120 and 160 mg/kg/day after nine weeks of immunosuppression with dexamethasone to facilitate the development of acute Pneumocystis carinii penumoniae (PCP). Results: Untreated animals showed P. carinii infection levels with a mean (aplusmn;standard deviation) log number of cysts per gram of lung tissue of 4.6aplusmn;1.6 at the end of the experiment. Terbinafine administered at a dose of 160 mg/kg/day significantly reduced the log number of cysts per gram to 2.2aplusmn;1.5. The therapeutic efficacy of terbinafine administered at 160 mg/kg/day (log 2.2aplusmn;1.5 cysts/lung) was similar to that obtained with trimethoprim-sulfamethoxazole (TMP-SMX), 50/250 mg/kg/day (palt;0.001). A reduction in the number of cysts was also observed in infected animals treated with 80, and 120 mg of terbinafine/kg/day, although the results were not statistically significant (pagt;0.05). Conclusion: In our model, the efficacy of terbinafine in PCP has been found to be dose dependent. Turkish Baslik: Pneumocystis cariniia#39;ye Terbinafinin Etkisinin Rat Modelinde Degerlendirilmesi Anahtar Kelimeler: Pneumocystis carinii; rat modeli; terbinafin Amac: Bu calisma rat modelinde terbinafinin anti-Pneumocystis aktivitesini belirlemek icin planlanmistir. Gerec ve Yontemler: Ratlar Erciyes Universitesi Deneysel ve Klinik Arastirma Merkezina#39;den saglanmistir. Dokuz hafta boyunca akut Pneumocystis carinii pnomonisi (PCP) olusturmak uzere, deksamethazon ile immunsupresyon yapilan ratlara oral olarak 40, 80, 120 ve 160 mg/kg/gun terbinafin verildi. Bulgular: Calismanin sonunda tedavi almayan grupda PCP enfeksiyon duzeyi ortalama (aplusmn;standart sapma) akciger dokusu gramindaki kist sayisi log 4.6aplusmn;1.6 idi. Terbinafin 160mg/kg/gun uygulanan grupta gramdaki kist sayisinda onemli dusus gozlendi log 2.2aplusmn;1.5. Terbinafin 160mg/kg/gun uygulanan tedavi etkinligi, trimetoprim-sulfametoksazol (TMP-SMX), 50/250 mg/kg/gun uygulamasi ile benzer sonuc verdi (palt;0.001). Terbinafin 80 ve 120 mg/kg/gun uygulamalarinda da kist sayisinda dusus gorulmekle birlikte bu degerler istatistiksel olarak anlamli degildi (pagt;0.05). Sonuc: Bizim modelimizde terbinafinin PCP etkinligi doza bagli bulundu.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom